Melatonin inhibits migration and invasion of prostate cancer cells to surrounding cells by interacting with MT1 receptor, inhibiting other signaling pathways like phospholipase C (PLC), protein kinase 38 (p38), and c-Jun dependent pathways in DU145 and PC3 prostate cancer cell lines. The gene discussed is HSPG2; the disease is prostate carcinoma.